# RIVASTIGMINE TARTRATE
> **ANDA077129** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 2008-01-08
## Drug
- **FDA Application Number:** ANDA077129
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVASTIGMINE TARTRATE
- **Generic name:** Rivastigmine Tartrate
- **Active ingredients:** RIVASTIGMINE TARTRATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS
- **First approval:** 2008-01-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077129)
---
*MORVS · CC0 1.0*